Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miriam Wittmann

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Current Opinion in Allergy and Clinical Immunology|September 7, 2006
Interaction of keratinocytes with infiltrating lymphocytes in allergic eczematous skin diseasesMiriam Wittmann, Thomas Werfel
Recent Patents on Inflammation & Allergy Drug Discovery|July 26, 2012
Therapeutic strategies in allergic contact dermatitisAdewonuola Alase, Miriam Wittmann
Dermatology and Therapy|July 27, 2013
Phosphodiesterase 4 inhibition in the treatment of psoriasis, psoriatic arthritis and other chronic inflammatory diseasesMiriam Wittmann, Philip S Helliwell
The British Journal of Dermatology|May 24, 2023
Hand eczema leaves systemic tracesLennart M Roesner, Miriam Wittmann
Cytokine & Growth Factor Reviews|August 29, 2014
Cytokines as therapeutic targets in skin inflammationMiriam Wittmann, Dennis McGonagle, Thomas Werfel
Experimental Dermatology|November 19, 2011
Human keratinocytes express AIM2 and respond to dsDNA with IL-1β secretionVerena Kopfnagel, Miriam Wittmann, Thomas Werfel
Experimental Dermatology|June 19, 2008
Keratinocytes enriched for epidermal stem cells differ in their response to IFN-gamma from other proliferative keratinocytesJana Zeitvogel, Thomas Werfel, Miriam Wittmann
Experimental Dermatology|May 25, 2012
IL-27 acts as a priming signal for IL-23 but not IL-12 production on human antigen-presenting cellsJana Zeitvogel, Thomas Werfel, Miriam Wittmann
The Journal of Investigative Dermatology|February 18, 2006
IL-13-stimulated human keratinocytes preferentially attract CD4+CCR4+ T cells: possible role in atopic dermatitisRahul Purwar, Thomas Werfel, Miriam Wittmann
The Journal of Investigative Dermatology|September 24, 2022
Toward Cannabinoid Use for Refractory Cutaneous DermatomyositisMiriam Wittmann, Petra Staubach, Dennis McGonagle
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Current Opinion in Allergy and Clinical Immunology|September 7, 2006
Interaction of keratinocytes with infiltrating lymphocytes in allergic eczematous skin diseasesMiriam Wittmann, Thomas Werfel
Recent Patents on Inflammation & Allergy Drug Discovery|July 26, 2012
Therapeutic strategies in allergic contact dermatitisAdewonuola Alase, Miriam Wittmann
Dermatology and Therapy|July 27, 2013
Phosphodiesterase 4 inhibition in the treatment of psoriasis, psoriatic arthritis and other chronic inflammatory diseasesMiriam Wittmann, Philip S Helliwell
The British Journal of Dermatology|May 24, 2023
Hand eczema leaves systemic tracesLennart M Roesner, Miriam Wittmann
Cytokine & Growth Factor Reviews|August 29, 2014
Cytokines as therapeutic targets in skin inflammationMiriam Wittmann, Dennis McGonagle, Thomas Werfel
Experimental Dermatology|November 19, 2011
Human keratinocytes express AIM2 and respond to dsDNA with IL-1β secretionVerena Kopfnagel, Miriam Wittmann, Thomas Werfel
Experimental Dermatology|June 19, 2008
Keratinocytes enriched for epidermal stem cells differ in their response to IFN-gamma from other proliferative keratinocytesJana Zeitvogel, Thomas Werfel, Miriam Wittmann
Experimental Dermatology|May 25, 2012
IL-27 acts as a priming signal for IL-23 but not IL-12 production on human antigen-presenting cellsJana Zeitvogel, Thomas Werfel, Miriam Wittmann
The Journal of Investigative Dermatology|February 18, 2006
IL-13-stimulated human keratinocytes preferentially attract CD4+CCR4+ T cells: possible role in atopic dermatitisRahul Purwar, Thomas Werfel, Miriam Wittmann
The Journal of Investigative Dermatology|September 24, 2022
Toward Cannabinoid Use for Refractory Cutaneous DermatomyositisMiriam Wittmann, Petra Staubach, Dennis McGonagle
Pageof 9